Challenges and Visions for Infectious Diseases in Colombia during the COVID-19 Peripandemic Transition 2021-2023

Rodríguez‐Morales, Alfonso J.; Camacho-Moreno, Germán; Mendoza-Ramírez, Henry; Rodríguez-Sabogal, Iván Arturo; Oñate, José Millán

doi:10.22354/in.v26i2.1007

Cited by 3 publications

(2 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Posteriormente, y a pesar de las extensas medidas de contención, la enfermedad ha continuado avanzando hasta afectar al resto de los países de Asia, Medio Oriente y Europa. El 11 de marzo, la COVID-19 fue declarada como pandemia en una rueda de prensa mundial por Tedros Adhanom Ghebreyesus, director general de la Organización Mundial de la Salud (10,11). Actualmente, el virus SARS-CoV-2 sigue en circulación y no para de evolucionar.…”

Section: Generalidadesunclassified

Mortalidad antes y después de la vacunación de Covid-19 del 2020-2021

Ramos Morán,

Fuentes Madrid

2024

Rev.méd.sinerg.

View full text Add to dashboard Cite

Este artículo de publicación presenta una investigación sobre el impacto de la vacunación para la disminución de la mortalidad y la positividad de casos de COVID-19 en Honduras. Se recopilaron datos de hospitales y centros de salud en la Región Metropolitana de San Pedro Sula y la región de salud departamental de Copán. Se analizó un total de 123 148 muestras, de las cuales 47 578 fueron positivas, con una positividad del 38.63%. Se registraron 1827 fallecimientos en ambos lugares. Además, se observó una reducción en el número de muertes en los meses de octubre y noviembre, debido a la participación en el proceso de vacunación. Se destaca la importancia de que las personas que aún no se han vacunado lo hagan.

show abstract

Section: Generalidadesunclassified

Mortalidad antes y después de la vacunación de Covid-19 del 2020-2021

Ramos Morán,

Fuentes Madrid

2024

Rev.méd.sinerg.

View full text Add to dashboard Cite

show abstract

“…The post-acute sequelae SARS-CoV-2 infection (PASC) has emerged as a signi cant concern [1][2][3] , particularly among young individuals with a previous diagnosis of COVID-19 [4][5][6][7] . De ned by the World Health Organization (WHO) as the persistence of at least one physical symptom for 12 weeks following initial testing without an alternative diagnosis and expanded by the National Institutes of Health (NIH) to include ongoing, relapsing, or new symptoms four or more weeks post-acute infection, PASC potentially affects a signi cant proportion of COVID-19 survivors [8][9][10] .…”

Section: Introductionmentioning

confidence: 99%

Racial/Ethnic Differences in Long-COVID-Associated Symptoms among Pediatrics Population: Findings from Difference-in-differences Analyses in RECOVER Program

Chen,

Zhang,

Zhang

et al. 2024

Preprint

View full text Add to dashboard Cite

Racial/ethnic differences are associated with the potential symptoms and conditions of post-acute sequelae SARS-CoV-2 infection (PASC) in adults. These differences may exist among children and warrant further exploration. We conducted a retrospective cohort study for children and adolescents under the age of 21 from the thirteen institutions in the RECOVER Initiative. The cohort is 225,723 patients with SARS-CoV-2 infection or COVID-19 diagnosis and 677,448 patients without SARS-CoV-2 infection or COVID-19 diagnosis between March 2020 and October 2022. The study compared minor racial/ethnic groups to Non-Hispanic White (NHW) individuals, stratified by severity during the acute phase of COVID-19. Within the severe group, Asian American/Pacific Islanders (AAPI) had a higher prevalence of fever/chills and respiratory symptoms, Hispanic patients showed greater hair loss prevalence in severe COVID-19 cases, while Non-Hispanic Black (NHB) patients had fewer skin symptoms in comparison to NHW patients. Within the non-severe group, AAPI patients had increased POTS/dysautonomia and respiratory symptoms, and NHB patients showed more cognitive symptoms than NHW patients. In conclusion, racial/ethnic differences related to COVID-19 exist among specific PASC symptoms and conditions in pediatrics, and these differences are associated with the severity of illness during acute COVID-19.

show abstract

General Hospitalization and Intensive Care Unit-Related Factors of COVID-19 Patients in Northeastern Colombia: Baseline Characteristics of a Cohort Study

Cáceres Ramírez,

Lora Mantilla,

Parra Gómez

et al. 2023

Cureus

View full text Add to dashboard Cite

This study aims to describe demographic and clinical characteristics and the factors associated with the risk of COVID-19 general hospitalization and intensive care unit (ICU) care of patients who consulted in a thirdlevel hospital in Santander, Colombia. MethodsWe used baseline data from an ambidirectional cohort study. We included all patients with positive real-time polymerase chain reaction (PCR) tests for COVID-19 who came to the emergency room (ER) for respiratory symptoms related to COVID-19. Information regarding patients' baseline characteristics and symptoms was collected through telephone interviews and review of medical records. Vital signs were extracted from medical records as well. ResultsWe enrolled 3,030 patients, predominantly men, with a median age of 60 (interquartile range (IQR): 44-73). Symptoms of the acute phase varied between men and women. Men presented with more respiratory symptoms, and women had general symptoms. Hypertension, obesity, and diabetes were common risk factors for hospital admission. Antibiotic consumption may also play a role in hospital admission. ConclusionsMale sex, older age, hypertension, obesity, prior thrombotic events, and self-medicated antibiotics were associated with general hospitalization. Hypertension, obesity, diabetes, and cancer were associated with ICU admission. The Charlson comorbidity index (CCI) is a powerful tool for evaluate the impact of preexisting health conditions on COVID-19 hospital admission. We highlight the importance of these findings as possible predictors in our region.

show abstract

Challenges and Visions for Infectious Diseases in Colombia during the COVID-19 Peripandemic Transition 2021-2023

Abstract: Challenges and Visions for Infectious Diseases in Colombia during the COVID-19 Peripandemic Transition 2021-2023

Cited by 3 publications

References 40 publications

Mortalidad antes y después de la vacunación de Covid-19 del 2020-2021

Mortalidad antes y después de la vacunación de Covid-19 del 2020-2021

Racial/Ethnic Differences in Long-COVID-Associated Symptoms among Pediatrics Population: Findings from Difference-in-differences Analyses in RECOVER Program

General Hospitalization and Intensive Care Unit-Related Factors of COVID-19 Patients in Northeastern Colombia: Baseline Characteristics of a Cohort Study

Contact Info

Product

Resources

About